| Design, execution, and analysis of CRISPR–Cas9-based deletions and genetic interaction networks in the fungal pathogen Candida albicans V Halder, CBM Porter, A Chavez, RS Shapiro Nature protocols 14 (3), 955-975, 2019 | 33 | 2019 |
| A data library of Candida albicans functional genomic screens NC Gervais, V Halder, RS Shapiro FEMS Yeast Research 21 (7), foab060, 2021 | 8 | 2021 |
| Genetic interaction analysis in microbial pathogens: unravelling networks of pathogenesis, antimicrobial susceptibility and host interactions V Halder, B McDonnell, D Uthayakumar, J Usher, RS Shapiro FEMS microbiology reviews 45 (3), fuaa055, 2021 | 7 | 2021 |
| The SAGA and NuA4 component Tra1 regulates Candida albicans drug resistance and pathogenesis I Razzaq, MD Berg, Y Jiang, J Genereaux, D Uthayakumar, GH Kim, ... Genetics 219 (2), iyab131, 2021 | 5 | 2021 |
| Characterizing a novel antimicrobial molecule effective for drug-resistant pathogens and bacterial biofilm that augments keratinocyte migration V Maksimoska, C Goodall, V Halder, M Agyare-Tabbi, ... The Microbe 2, 100032, 2024 | | 2024 |
| Conducting genetic interaction analysis with CRISPR-Cas9-based strategies in Candida albicans V Halder, B McDonnell, R Shapiro Access Microbiology 3 (12), po0194, 2021 | | 2021 |
| A novel CRISPRi platform to study the role of essential genes in antifungal drug-resistant Candida albicans isolates L Wensing, R Shapiro, D Uthayakumar, V Halder, J Sharma, Y Proteau, ... Access Microbiology 3 (12), po0157, 2021 | | 2021 |
| Design, execution, and analysis of CRISPR-Cas9-based deletions and genetic interaction networks in the fungal pathogen Candida albicans (vol 14, pg 955, 2019) V Halder, C Porter, A Chavez, RS Shapiro NATURE PROTOCOLS 14 (8), 2595-2595, 2019 | | 2019 |
